PETRILLO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 7.415
AS - Asia 3.471
SA - Sud America 2.289
EU - Europa 1.248
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 150
OC - Oceania 14
AN - Antartide 1
Totale 14.829
Nazione #
US - Stati Uniti d'America 7.212
BR - Brasile 2.043
SG - Singapore 1.749
CN - Cina 554
IT - Italia 413
HK - Hong Kong 376
VN - Vietnam 271
FR - Francia 167
UA - Ucraina 164
DE - Germania 133
AR - Argentina 88
BD - Bangladesh 79
TR - Turchia 75
GB - Regno Unito 70
MX - Messico 67
CA - Canada 57
EC - Ecuador 51
RU - Federazione Russa 49
ES - Italia 41
UZ - Uzbekistan 41
ZA - Sudafrica 41
IN - India 40
FI - Finlandia 36
JP - Giappone 35
IQ - Iraq 32
MA - Marocco 31
NL - Olanda 29
PK - Pakistan 25
VE - Venezuela 25
CO - Colombia 23
CL - Cile 20
AZ - Azerbaigian 18
CR - Costa Rica 18
AE - Emirati Arabi Uniti 17
KE - Kenya 17
PL - Polonia 17
TN - Tunisia 17
AT - Austria 16
ID - Indonesia 15
KR - Corea 15
IE - Irlanda 14
NP - Nepal 14
SE - Svezia 14
AU - Australia 13
EG - Egitto 13
PE - Perù 13
BE - Belgio 12
JM - Giamaica 12
JO - Giordania 12
KZ - Kazakistan 12
OM - Oman 10
PY - Paraguay 10
DO - Repubblica Dominicana 9
PS - Palestinian Territory 9
UY - Uruguay 9
DZ - Algeria 8
IL - Israele 8
LB - Libano 8
RO - Romania 8
BY - Bielorussia 7
CH - Svizzera 7
KW - Kuwait 7
MY - Malesia 7
AO - Angola 6
CZ - Repubblica Ceca 6
GR - Grecia 6
HN - Honduras 6
NI - Nicaragua 6
PA - Panama 6
PH - Filippine 6
RS - Serbia 6
AL - Albania 5
GT - Guatemala 5
KG - Kirghizistan 5
PR - Porto Rico 5
BG - Bulgaria 4
BH - Bahrain 4
BN - Brunei Darussalam 4
DK - Danimarca 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
SA - Arabia Saudita 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
LT - Lituania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
CG - Congo 2
CU - Cuba 2
CY - Cipro 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GF - Guiana Francese 2
IR - Iran 2
MK - Macedonia 2
MU - Mauritius 2
Totale 14.564
Città #
Dallas 2.747
Singapore 1.015
Chandler 831
San Jose 664
Hong Kong 371
Ashburn 280
Santa Clara 257
Columbus 248
Council Bluffs 240
Princeton 240
Beijing 181
São Paulo 137
Lauterbourg 132
Wilmington 115
Ho Chi Minh City 97
The Dalles 91
Shanghai 87
New York 69
Rio de Janeiro 68
Hanoi 61
Los Angeles 52
Belo Horizonte 51
Rome 47
Tashkent 40
Brasília 38
Frankfurt am Main 38
Sassari 34
Tokyo 34
Salvador 31
Orem 30
Campinas 29
Falls Church 29
Helsinki 26
San Francisco 26
Curitiba 24
Guarulhos 24
Porto Alegre 24
Brooklyn 23
Munich 21
Toronto 21
Chicago 20
Milan 20
Norwalk 20
Da Nang 18
Mexico City 18
Istanbul 17
Johannesburg 17
Manaus 17
Sorocaba 17
Atlanta 16
Quito 16
San José 16
Baku 15
Boardman 15
Jacksonville 15
Nairobi 15
Nuremberg 15
Ribeirão Preto 15
Seoul 15
Ankara 14
Campo Grande 14
Cape Town 14
Contagem 14
Praia Grande 14
Amsterdam 13
Ann Arbor 13
Osasco 13
Warsaw 13
Amman 12
Baghdad 12
Brussels 12
Chennai 12
Falkenstein 12
London 12
Manchester 12
Montreal 12
Recife 12
Uberlândia 12
Boston 11
Düsseldorf 11
Goiânia 11
Houston 11
Tianjin 11
Buffalo 10
Cagliari 10
Denver 10
Guayaquil 10
Santo André 10
Bogotá 9
Cotia 9
Dhaka 9
Lahore 9
Montevideo 9
Phoenix 9
Rio Grande 9
São José dos Campos 9
Vila Velha 9
Volta Redonda 9
Caxias do Sul 8
Chengdu 8
Totale 9.343
Nome #
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 326
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project 322
Exploring Vascular Complications in Ovarian Cancer Surgery: A Narrative Literature Review with a New Management Proposal Algorithm 312
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 299
Short- and long-term outcomes of vaginal, laparoscopic, and robotic-assisted surgery in “oldest old” endometrial cancer 272
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 190
Primary extranodal vaginal non-hodgkin lymphoma: Diagnostic pitfalls and therapeutic challenges 182
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 166
Materno-Fetal and Neonatal Complications of Diabetes in Pregnancy: A Retrospective Study 145
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 145
Efficacy and effectiveness of the bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis 144
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 143
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 143
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 141
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience 139
Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma 138
A case of isolated ovarian recurrence from vulvar carcinoma 138
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 137
A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 135
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 134
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison 134
ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer 133
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 132
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study 131
Comparison of perioperative outcomes between standard laparoscopic and robotic-assisted approach in patients with rectosigmoid endometriosis 131
CD133 antigen expression in ovarian cancer 124
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study 123
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 121
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 120
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 119
Conservatively treated glassy cell carcinoma of the cervix 117
Native tissue repair (NTR) versus transvaginal mesh interventions for the treatment of anterior vaginal prolapse: Systematic review and meta-analysis 113
Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment 112
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 110
The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community 110
The impact of COVID-19 lockdown on admission to gynecological emergency department: results from a a multicenter italian study 110
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: A retrospective longitudinal analysis using matched tumor biopsies 110
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: The experience at Gemelli hospital and a literature review 108
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 104
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer 103
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 102
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer 102
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 102
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 101
Fetal Growth and Neonatal Outcomes in Pregestational Diabetes Mellitus in a Population with a High Prevalence of Diabetes 101
Characteristics and outcomes of surgically staged multiple classifier endometrial cancer 100
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 99
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness 98
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 98
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer 96
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 96
Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical cancer 96
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 95
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 94
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy 94
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy 92
Self-reported long-term autonomic function after laparoscopic total mesometrial resection for early-stage cervical cancer: A multicentric study 92
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 91
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients 90
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: A case report and review of the literature 90
Lidocaine spray vs mepivacaine local infiltration for suturing 1st/2nd grade perineal lacerations: a randomised controlled non-inferiority trial 89
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series 89
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 88
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results 88
Incidence and predictive factors for complications after uterine leiomyoma embolization 87
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 87
Non-catalytic region of tyrosine kinase adaptor protein 2 (Nck2) pathways as factor promoting aggressiveness in ovarian cancer 86
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes 86
Targeting the hallmarks of ovarian cancer: The big picture 86
Impact of postoperative cardiovascular complications on 30‐day mortality after major abdominal surgery: an international prospective cohort study 85
Secondary cytoreduction in ovarian cancer: who really benefits? 85
Ovarian low and high grade serous carcinomas: Hidden divergent features in the tumor microenvironment 85
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 85
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis 85
Glassy cell carcinoma of the endometrium: A case report and review of the literature 84
Novel targets for VEGF-independent anti-angiogenic drugs 84
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 84
Vulvar squamous cell carcinoma with sarcoma-like stroma: A case report and review of the literature 84
Modulation of adipose-derived stem cell behavior by prostate pathology-associated plasma: insights from in vitro exposure 83
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer 83
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 82
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study 82
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study 82
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer 82
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 82
Postmenopausal recurrent cystitis treatment with intravesical hyaluronic acid and chondroitin sulphate: a patient-reported outcome study 81
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction 81
Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study 81
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study 81
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 80
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? 80
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome 80
Expression and subcellular localization of CRH and its receptors in human endometrial cancer 79
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer 79
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 78
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 78
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 78
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 76
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 76
Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients 76
Totale 11.352
Categoria #
all - tutte 67.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022540 0 0 9 13 25 22 11 46 61 49 68 236
2022/20231.454 151 54 20 266 128 248 2 211 286 12 50 26
2023/2024332 81 31 17 11 23 15 15 35 0 3 27 74
2024/20254.406 59 33 250 123 211 174 307 950 1.522 496 175 106
2025/20266.796 226 1.300 1.835 579 652 270 884 191 296 314 139 110
2026/2027909 164 500 245 0 0 0 0 0 0 0 0 0
Totale 14.829